About Us

About us

EKF Diagnostics Holdings plc is a global manufacturer of medical diagnostic products and services headquartered in Cardiff, UK and with facilities in Europe and the USA.

EKF sells through a network of distributors around the world; however our German and American offices also sell directly into hospital laboratories, GP surgeries as well as into universities and sports organisations.

EKF Diagnostics is listed on AIM on the London Stock Exchange. The business has four key divisions, shown below, each of which has it's own unique set of attributes.


iconSquareswithoutText PointofCare

Point of Care

EKF Point of Care (POC) analyzers are designed for use within doctors' surgeries, clinics, blood banks and hospital and private laboratories to provide fast and accurate results at an affordable price.

iconSquareswithoutText CentralLab

Central Laboratory

EKF's Central Laboratory division manufactures a wide spectrum of reagents for use in hospital laboratories. It also supplies benchtop automated and semi-automated analysers, as well as centrifuges and some rapid test kits.

iconSquareswithoutText LifeSciences

Life Sciences

EKF Life Sciences specializes in producing enzymes and contracted custom products for use in medical diagnostics, pharmaceuticals and industry. EKF Life Science facilities are based in two locations in Indiana, USA.


Contract Manufacturing

EKF Contract Manufacturing provides specialized services to the diagnostics and healthcare industries for the production of custom kits. With facilities in the US, UK and Germany EKF is able to provide bulk formulation, dispensing and kitting services, as well as provide advice and guidance on Regulatory requirements. EKF's end-to-end service also includes sourcing, print and compilation of packaging, IFUs and labelling.


Quality Standards

All EKF's facilities are accredited by the international standards agencies that oversee the design and manufacture of medical devices. EKF-diagnostic GmbH and Stanbio Laboratory are both FDA registered facilities, whilst Stanbio is also accredited by the Canadian Medical Devices Conformity Assessment Scheme (CMDCAS).

A global diagnostics company

EKF is a global company with offices in the UK, Germany, USA, Russia and China and counts with a network of more than 200 distributors covering every country.



We keep our network up-to-date with our products with constant training and attending to global events like Medica, MedLab or AACC across countries.



EKF Map V2 2023



Careers at EKF Diagnostics

EKF Diagnostics is a global medical manufacturer of Point-of-Care and Central Laboratory devices and tests including hemoglobin tests, HbA1c tests, glucose and lactate tests.

The UK office is headquarters to our finance and marketing teams and a newly opened lab facility. Our German office is home to EKF's manufacturing, R&D and Regulatory Affairs departments for our Point of Care range. EKF also has manufacturing sites in San Antonio and Indiana in the USA.



EKF Diagnostics Holdings plc (UK)

There are currently no vacancies available.

EKF-diagnostic GmbH (Germany)

See our vacancies at EKF-diagnostic GmbH which is based near Magdeburg, in Germany.

EKF USA and Life Sciences

See our vacancies for the US.

Company timeline


EKF Industrie-Elektronik established. This company would go on to develop Hemo Control and Biosen.



EKF Industrie-Elektronik renamed EKF-diagnostic GmbH.


EKF-diagnostic sales GmbH and EKF-diagnostic Russia founded.


SensLab GmbH is acquired adding Lactate Scout to the Sport Performance range.



EKF-diagnostyka Poland founded.


EKF GmbH acquired by IBL plc and is listed on London Stock Exchange as EKF Diagnostics Holdings plc.

Quotient Diagnostics Ltd and Argutus Medical Ltd subsequently acquired to expand the Diabetes Care portfolio with the Quo-Lab and Quo-Test HbA1c analysers along with the predictive kidney biomarker sTNFR1.



Stanbio Laboratory acquired by EKF Diagnostics Holdings plc adding a Clinical Chemistry portfolio of more than a 80 reagents, controls, calibrators, and standards, as well as a enzyme manufacturing plant in Elkhart now known as EKF Life Sciences.


DiaSpect Medical AB and Separation Technology acquired to supplement EKF's hemoglobin range with DiaSpect and UltraCrit.



Manufacturing consolidated into two sites - Barleben, near Magdeburg in Germany and Boerne, near San Antonio in Texas.



EKF Diagnostics announces record revenues and profitability, as well as the successful floatation of spin-out, Renalytix AI, on AIM.


Production starts in the USA, UK and Germany of PrimeStore MTM - a transport media for samples that may contain an infection disease such as COVID-19, influenza or TB.

timeline - PrimeStore


Trellus Health, a joint venture with Mount Sinai, admitted to AIM. 

Acquisition of ADL Health, a CLIA certified lab in San Antonio, Texas which specialises in quick-turnaround COVID-19 testing for companies and individuals.


Investor Relations